Plain-English translation of NCT06842316 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying how phytocannabinoids—natural compounds from the cannabis plant—might help calm the immune system in people with chronic inflammatory diseases. The study will test blood samples from patients with conditions like rheumatoid arthritis, lupus, Sjögren's syndrome, and inflammatory bowel disease to see how the medication affects immune cells and inflammation.
Many people with inflammatory diseases suffer from pain and swelling that current treatments don't fully control. This treatment may have anti-inflammatory properties that could help reduce symptoms, but doctors need to understand exactly how it works in the immune system before it can be used more widely.
You likely qualify if…
You likely don't qualify if…
You would provide blood samples that researchers will test in the laboratory to see how phytocannabinoids affect your immune cells and inflammation markers. The study compares results across different patient groups—some taking no special treatment, others on standard medicines, and others on newer biologic therapies—to understand how the compounds work in different situations. You would continue your regular medical care and medications throughout the study.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
France